4//SEC Filing
Henrich Jill 4
Accession 0000905148-25-000863
CIK 0001604464other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:16 PM ET
Size
5.1 KB
Accession
0000905148-25-000863
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2025-03-03$7.00/sh−1,059$7,410→ 18,679 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
- [F3]This amount includes 360 shares purchased under the Issuer's Employee Stock Purchase Plan on November 29, 2024.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001978096
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:16 PM ET
- Size
- 5.1 KB